Department of Defense Archives
New target to stop Ebola
May. 21, 2018—A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.
Study seeks new ways to detect sensory issues in TBI patients
Oct. 26, 2017—Vanderbilt researcher Tonia Rex, Ph.D., is accustomed to performing studies in her lab with a goal of translating the findings into better diagnoses and treatment tools for the visually impaired.
Harris honored for support of employees’ military service
Jul. 27, 2017—Kaye Harris, MSN, R.N., manager of Supplemental Staffing Programs, has received a Patriotic Employer Award from the Employer Support of the Guard and Reserve (ESGR), a program of the Department of Defense.
Genetics of lung cancer survival
Jun. 29, 2017—Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.
Blood type link to cancer survival
May. 17, 2017—Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study.
Studies aim to speed, track peripheral nerve recovery
Oct. 6, 2016—Surgeons have limited tools to successfully repair and track the recovery of peripheral nerves that have been severely damaged as a result of a traumatic injury, but Vanderbilt investigators hope to change this through research studies recently funded with more than $3 million in grants from the Department of Defense and the National Institutes of Health.
New breast cancer driver
Aug. 26, 2016—Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.
Breast cancer: finding the smoking gun
Jul. 20, 2016—A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes.
Drug combos enhance ovarian cancer cell death
Aug. 11, 2015—Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities.
Neurofibromin fine-tunes bone growth
May. 6, 2015—The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered.
Vanderbilt to study use of plasma on LifeFlight, extends trial to Rutherford County base
Feb. 25, 2015—Vanderbilt University Medical Center is participating in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Randomized patients who are at risk of hemorrhaging could receive two units of plasma, which can improve a patient’s...
Key to prostate cancer resistance
Oct. 29, 2014—A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.